MarketWatch: Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy(R), offering savings of up to $1,200/year
Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy(R), offering savings of up to $1,200/year
Seeking Alpha: Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year
Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year
Novo Nordisk is launching a subscription plan for its blockbuster GLP-1 weight loss drug Wegovy. The debut offers lower monthly prices to eligible cash-paying patients. Available through select ...
Fierce Healthcare: Novo Nordisk launches discounted subscription program for Wegovy through telehealth providers
Novo Nordisk rolled out a multi-month subscription plan for Wegovy, the “first and only” program of its kind that the manufacturer says could save users up to $1,200 annually. The new program aims to ...
Novo Nordisk has made a higher-dose version of its blockbuster weight-loss drug Wegovy available across the United States. The 7.2-milligram dose, branded as Wegovy HD, gained approval under the FDA ...
Novo Nordisk has released a higher-dose version of its weight-loss drug Wegovy, now available in the U.S. The 7.2-mg dose, named Wegovy HD, was approved recently. While its retail price is $399 ...
Reuters on MSN: Novo Nordisk launches higher-dose Wegovy in the United States
April 7 (Reuters) - Novo Nordisk said on Tuesday that it has made a higher-dose version of its blockbuster weight-loss drug Wegovy available across the United States. The 7.2-milligram dose, branded ...
Invezz on MSN: Can Wegovy HD 7.2 mg drive Novo Nordisk’s obesity drug rebound?